North Shore-LIJ spinoff lands $28.8M drug trial agreement

By June 4, 2015 VRG News No Comments

Vanguard Research Group, a Manhasset company owned by North Shore-Long Island Jewish Health System and one of its executives, has signed a four-year, $28.8 million agreement to manage a clinical trial for an injectable form of a schizophrenia drug.

Read the article on Newsday

About VRG

Leave a Reply

Want to learn more about VRG or sign up for VRG's services? Contact Us